August 25th 2025
Leqembi for the treatment of Alzheimer disease has been launched in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025—the first launches in the EU.
8 Neuropsychiatric Symptoms and Treatments of Huntington Disease
In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.
Read More
Vital Amines: The Who, What, When, Where, Why, and How of Folate Deficiency
March 17th 2021A myriad of neuropsychiatric symptoms result from folate deficiency, including cognitive impairment, insomnia, psychosis, depression, peripheral sensory deficits, and weakness. Treatment and prevention strategies are discussed.
Read More
Early Warnings: Neuropsychiatric Manifestations of Huntington Disease
Neuropsychiatric manifestations of Huntington disease can present decades before the motor symptoms become apparent, making the role of the psychiatrist all the more important.
Read More
Smart Growth: the Case for Measuring Brain Capital
Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?
Read More